KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Capital Employed (2019 - 2025)

Vir Biotechnology (VIR) has disclosed Return on Capital Employed for 7 consecutive years, with 0.52% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 8.0% to 0.52% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.52% through Dec 2025, down 8.0% year-over-year, with the annual reading at 0.43% for FY2025, 5.0% down from the prior year.
  • Return on Capital Employed hit 0.52% in Q4 2025 for Vir Biotechnology, up from 0.53% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.93% in Q1 2022 to a low of 0.58% in Q1 2021.
  • Historically, Return on Capital Employed has averaged 0.15% across 5 years, with a median of 0.35% in 2023.
  • Biggest five-year swings in Return on Capital Employed: surged 150bps in 2022 and later plummeted -107bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.34% in 2021, then grew by 10bps to 0.37% in 2022, then plummeted by -202bps to 0.38% in 2023, then dropped by -17bps to 0.44% in 2024, then fell by -18bps to 0.52% in 2025.
  • Business Quant data shows Return on Capital Employed for VIR at 0.52% in Q4 2025, 0.53% in Q3 2025, and 0.53% in Q2 2025.